Samuel T. Barnett
Direktor/Vorstandsmitglied bei Friends Life Care Partners
Profil
Samuel T.
Barnett is currently a Director at Friends Life Care Partners.
Previously, he was a Director at Astralis Ltd.
from 2004 to 2007.
He holds a graduate degree and a doctorate from Temple University (Pennsylvania) and an undergraduate degree from Wesleyan University.
Aktive Positionen von Samuel T. Barnett
| Unternehmen | Position | Beginn |
|---|---|---|
Friends Life Care Partners
 Friends Life Care Partners Medical/Nursing ServicesHealth Services Friends Life Care Partners provides Home care, health and wellness programs and services. The company was founded in 1982 and is headquartered in Plymouth Meeting, PA. | Direktor/Vorstandsmitglied | - |
Ehemalige bekannte Positionen von Samuel T. Barnett
| Unternehmen | Position | Ende |
|---|---|---|
Astralis Ltd.
 Astralis Ltd. BiotechnologyHealth Technology Astralis Ltd. research and develop drugs for the treatment of immune system disorders and skin diseases. The company's initial product is Psoraxine, a protein extract used for the treatment of the skin disease psoriasis. Psoraxine is a synthesized immuno-therapeutic agent, presented in liquid form and is packed in 0.5 mg ampules for intra-muscular injection. The company's second product is for the treatment of leishmaniasis. The company was founded on June 30, 2001 and is headquartered in Fairfield, NJ. | Direktor/Vorstandsmitglied | 07.03.2007 |
Ausbildung von Samuel T. Barnett
| Wesleyan University | Undergraduate Degree |
| Temple University (Pennsylvania) | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 2 |
|---|---|
Astralis Ltd.
Astralis Ltd. BiotechnologyHealth Technology Astralis Ltd. research and develop drugs for the treatment of immune system disorders and skin diseases. The company's initial product is Psoraxine, a protein extract used for the treatment of the skin disease psoriasis. Psoraxine is a synthesized immuno-therapeutic agent, presented in liquid form and is packed in 0.5 mg ampules for intra-muscular injection. The company's second product is for the treatment of leishmaniasis. The company was founded on June 30, 2001 and is headquartered in Fairfield, NJ. | Health Technology |
Friends Life Care Partners
Friends Life Care Partners Medical/Nursing ServicesHealth Services Friends Life Care Partners provides Home care, health and wellness programs and services. The company was founded in 1982 and is headquartered in Plymouth Meeting, PA. | Health Services |
